Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease
- PMID: 16387798
- PMCID: PMC2662947
- DOI: 10.1164/rccm.200510-1681OC
Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease
Abstract
Rationale: Recently, respiratory syncytial virus (RSV) RNA has been identified by reverse transcriptase-polymerase chain reaction (RT-PCR) from a high percentage of patients with stable chronic obstructive pulmonary disease (COPD). These data raise the possibility of persistent low-grade infection in this population, which could have implications in COPD pathogenesis.
Objectives: RSV persistence was investigated by testing respiratory secretions from subjects with COPD during illness and at regular intervals over 1 yr.
Methods: Nasal and sputum samples from subjects with COPD were tested by one-tube nested RT-PCR for RSV every 2 mo and during respiratory illnesses for 1 yr. Subjects positive for RSV were evaluated weekly until negative in two consecutive samples. Nasal secretions and serum were tested for RSV antibody. A rise of fourfold or greater was defined as evidence of RSV infection.
Results: A total of 112 patients were enrolled and the illnesses of 92 patients were evaluated. RSV was detected by RT-PCR in 6/92 (6.5%) illness nasal samples versus 0/685 routine nasal samples and in 5/69 (7.2%) illness sputum samples versus 3 /315 (0.9%) routine. Four additional RSV infections were identified by serum antibody responses. Of the RSV infections 86% were associated with serum or nasal antibody responses and 73% had symptoms of acute respiratory illness.
Conclusions: Most RSV infections in patients with COPD are associated with symptomatic respiratory illnesses and measurable immune responses. Our data do not support the concept of RSV persistence in this population.
Figures

Similar articles
-
Detection of adenovirus and respiratory syncytial virus in patients with chronic obstructive pulmonary disease: Exacerbation versus stable condition.Mol Med Rep. 2015 Aug;12(2):3039-46. doi: 10.3892/mmr.2015.3681. Epub 2015 Apr 24. Mol Med Rep. 2015. PMID: 25936369
-
Detection of respiratory syncytial virus and human metapneumovirus by reverse transcription polymerase chain reaction in adults with and without respiratory illness.J Clin Virol. 2006 Jan;35(1):46-50. doi: 10.1016/j.jcv.2005.04.004. J Clin Virol. 2006. PMID: 15919236
-
Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease.Am J Respir Crit Care Med. 2006 Apr 15;173(8):871-6. doi: 10.1164/rccm.200509-1489OC. Epub 2006 Feb 2. Am J Respir Crit Care Med. 2006. PMID: 16456141
-
Respiratory syncytial virus persistence in chronic obstructive pulmonary disease.Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S63-70. doi: 10.1097/INF.0b013e3181684d67. Pediatr Infect Dis J. 2008. PMID: 18820581 Review.
-
Respiratory syncytial virus persistence: evidence in the mouse model.Pediatr Infect Dis J. 2008 Oct;27(10 Suppl):S60-2. doi: 10.1097/INF.0b013e3181684d52. Pediatr Infect Dis J. 2008. PMID: 18820580 Review.
Cited by
-
Inhibition of human respiratory syncytial virus infectivity by a dendrimeric heparan sulfate-binding peptide.Antimicrob Agents Chemother. 2012 Oct;56(10):5278-88. doi: 10.1128/AAC.00771-12. Epub 2012 Jul 30. Antimicrob Agents Chemother. 2012. PMID: 22850525 Free PMC article.
-
Proton pump inhibitors for chronic obstructive pulmonary disease.Cochrane Database Syst Rev. 2020 Aug 25;8(8):CD013113. doi: 10.1002/14651858.CD013113.pub2. Cochrane Database Syst Rev. 2020. PMID: 32844430 Free PMC article.
-
Viral etiology of acute exacerbations of COPD in Hong Kong.Chest. 2007 Sep;132(3):900-8. doi: 10.1378/chest.07-0530. Epub 2007 Jun 15. Chest. 2007. PMID: 17573516 Free PMC article.
-
Novel genetically-modified chimpanzee adenovirus and MVA-vectored respiratory syncytial virus vaccine safely boosts humoral and cellular immunity in healthy older adults.J Infect. 2019 May;78(5):382-392. doi: 10.1016/j.jinf.2019.02.003. Epub 2019 Feb 8. J Infect. 2019. PMID: 30742894 Free PMC article. Clinical Trial.
-
Progress in respiratory virus vaccine development.Semin Respir Crit Care Med. 2011 Aug;32(4):527-40. doi: 10.1055/s-0031-1283289. Epub 2011 Aug 19. Semin Respir Crit Care Med. 2011. PMID: 21858754 Free PMC article. Review.
References
-
- Centers for Disease Control and Prevention. Chronic obstructive pulmonary disease surveillance—United States: 1971–2000. MMWR Morb Mortal Wkly Rep 2002;51:S1–S16.
-
- Seemungal TAR, Wedzicha JA. Viral infections in obstructive airway diseases. Curr Opin Pulm Med 2003;9:111–116. - PubMed
-
- Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418–1422. - PubMed
-
- Sethi S. New developments in the pathogenesis of acute exacerbations of chronic obstructive pulmonary disease. Curr Opin Infect Dis 2004;17:113–119. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical